Search

everythinglearnresearchcommunity

for

Search:↓

Growth factors greatly affect hair loss, with different levels seen in men, women, younger patients, and at the start of the condition.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

GLPLS is a rare skin condition with specific hair loss and skin symptoms.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

Dermatologists give better information on pathology forms, hypersensitivity vasculitis is a common skin issue, misdiagnoses can occur, and various skin conditions are linked to loss of elastin or genetic factors.

Topical finasteride with EGCG or TA improves drug release and dermal uptake, potentially treating hair loss effectively.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Lichen planopilaris should be considered when diagnosing hair loss in people with darker skin as it may be often missed.

Scarring alopecia causes permanent hair loss, and treatment aims to reduce inflammation and stop it from getting worse.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

The Brigham Eyelash Tool for Alopecia (BELA) is a reliable way to measure eyelash loss in alopecia areata patients.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

CRISPR/Cas9 has improved precision and control but still faces clinical challenges.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

The conclusion is that hair loss from CCCA may be genetic and not solely caused by hair grooming practices.

Various potential triggers may be causing the rise in frontal fibrosing alopecia, and avoiding these could help stop the disease's increase.

Photodynamic therapy may not work for erythroplasia of Queyrat and could lead to invasive squamous cell carcinoma.

Men with Frontal fibrosing alopecia typically lose hair on the front scalp and sometimes on sideburns and upper lip, with treatments showing varied success.

Intermediate filaments are crucial for cell differentiation and stem cell function.

Targeting and modifying the stem cell niche can improve regenerative therapies.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Choosing the right recall period for patient feedback is important for accurate data and depends on the disease, symptom changes, and patient impact.

Recognizing specific skin features helps diagnose and manage lupus erythematosus effectively.

Female pattern hair loss greatly affects quality of life, especially in younger patients, those with the condition for a long time, and those with mental health issues. A more comprehensive treatment approach is suggested.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

Treatment with dutasteride, minoxidil, and artificial hair transplantation improved appearance but caused folliculitis.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

The C3H/HeJ mouse model is useful for studying and testing treatments for alopecia areata.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.